Joshua S. Prince's most recent trade in VistaGen Therapeutics Inc was a trade of 4,882 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | Joshua S. Prince | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 30 Jun 2025 | 4,882 | 10,863 (0%) | 0% | 1.7 | 8,299 | Common Stock |
| VistaGen Therapeutics Inc | Joshua S. Prince | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Joshua S. Prince | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 2.51 per share. | 31 Dec 2024 | 3,310 | 5,981 (0%) | 0% | 2.5 | 8,300 | Common Stock |
| VistaGen Therapeutics Inc | Joshua S. Prince | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 2.96 per share. | 28 Jun 2024 | 2,671 | 2,671 (0%) | 0% | 3.0 | 7,901 | Common Stock |
| VistaGen Therapeutics Inc | Joshua S. Prince | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |